Error during command authentication.

Error - unable to initiate communication with LISTSERV (errno=111). The server is probably not started.

Print

---

Hi folks,

     Let's talk about the RESTORATION of  doaminergic brain stem cells,
instead of about their DEATH.  I've extracted this key phrase from the
post about the U.Colorado research, below:

   "....the potential of these proteins to restore dopaminergic neurons,
the brain cells damaged in
Parkinson's Disease, and promote the reestablishment of signaling
pathways in the central nervous system."

^^^^^^WARM GREETINGS  FROM^^^^^^^^^^^^^^^^^
Ivan Suzman         48/12/9.5         [log in to unmask]
Portland, Maine    Land of lighthouses    42   deg. F
********************************************************************

On Wed, 7 Oct 1998 00:45:00 -0400 judith richards <[log in to unmask]>
writes:
>Company Press Release
>
>SOURCE: Creative BioMolecules, Inc.
>
>Creative Biomolecules and The University of Colorado School of
>Medicine
>Receive Grant From NIH For Parkinson's Research
>
>HOPKINTON, Mass., Oct. 6, 1998 /PRNewswire/ -- Creative BioMolecules,
>Inc. announced today that it has received a Phase I Small Business
>Innovation Research (SBIR) grant from the National Institutes of
>Health (NIH) for research into morphogenic protein-based therapies for
>the treatment of Parkinson's Disease. The research is being conducted
>in
>collaboration with Paula C. Bickford, Ph.D., Associate Professor of
>Pharmacology at the University of Colorado's School of Medicine.
>
>Creative BioMolecules has proprietary rights to a family of
>neurotrophic
>proteins with demonstrated activity in multiple animal models of
>disease
>including stroke and initial results in Parkinson's Disease. This
>grant
>will support research to evaluate the potential of these proteins to
>restore dopaminergic neurons, the brain cells damaged in
>Parkinson's Disease, and promote the reestablishment of signaling
>pathways in the central nervous system.
>
>Dr. Bickford commented, ``Factors that promote the survival or prevent
>the progressive deterioration of dopaminergic neurons may have
>significant benefit in treating Parkinson's Disease. Early research
>indicates that OP-1 may represent the first protein in an exciting
>family of neurotrophic factors.''
>--
>Judith Richards, London, Ontario, Canada
><[log in to unmask]>
>                         ^^^
>                         \ /
>                       \  |  /   Today’s Research
>                       \\ | //         ...Tomorrow’s Cure
>                        \ | /
>                         \|/
>                       ```````
>